Guo-Ming Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Guo-Ming Zhang has a total of 83 co-authors. Here are the top co-authors by number of shared publications:
Xu-Xiao Guo
Department of Laboratory Medicine, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, Shandong, PR China
6 shared publications- Hemant Goyal
The Wright Center for Graduate Medical Education, Scranton, USA
5 shared publications Xiao-Bo Ma
Department of Laboratory Medicine, Shuyang People's Hospital, Shuyang Affiliated Hospital of Xuzhou Medical University, 223600 Shuyang, China
4 shared publicationsYe-Ting Zhou
Shuyang People's Hospital, Affiliated Shuyang Hospital, Xuzhou Medical University, Shuyang 223600, China
4 shared publicationsBao-Lin Zhu
3 shared publications- Bing Gu
South China University of Technology
3 shared publications
Latest Publications
- Open Access
- 29 September 2026
- Published by Springer Nature in European Journal of Medical Research
Selective direct bilirubin testing in outpatient liver chemistry: temporal validation and decision curve analysis
- 29 September 2026
- Published by Springer Nature in European Journal of Medical Research
Open AccessSelective direct bilirubin testing in outpatient liver chemistry: temporal validation and decision curve analysis
- 28 September 2026
- Published by Taylor & Francis in Biomarkers in Medicine
- p. 1-2
Clarifying the incremental value and implementation boundaries of combined pct and IL-6 in sepsis risk stratification
1. We read with interest the study by Xia et al. which evaluated the early prognostic value of combined procalcitonin (PCT) and interleukin-6 (IL-6) in patients with sepsis [1]. This topic is clini...
- 28 September 2026
- Published by Taylor & Francis in Biomarkers in Medicine
- p. 1-2
Clarifying the incremental value and implementation boundaries of combined pct and IL-6 in sepsis risk stratification
1. We read with interest the study by Xia et al. which evaluated the early prognostic value of combined procalcitonin (PCT) and interleukin-6 (IL-6) in patients with sepsis [1]. This topic is clini...
- Open Access
- 3 August 2026
- Published by Springer Nature in npj Digital Medicine
- Vol. 9 (1) , 592
Interpreting the clinical utility and generalizability of a multitask perioperative prediction model
- 3 August 2026
- Published by Springer Nature in npj Digital Medicine
- Vol. 9 (1) , 592
Open AccessInterpreting the clinical utility and generalizability of a multitask perioperative prediction model
- 13 April 2026
- Published by Taylor & Francis in Biomarkers in Medicine
- Vol. 20 (6) , 325-326
Commentary: diagnostic utility of procalcitonin for detecting bacteremia in persons who inject drugs
- 13 April 2026
- Published by Taylor & Francis in Biomarkers in Medicine
- Vol. 20 (6) , 325-326
Commentary: diagnostic utility of procalcitonin for detecting bacteremia in persons who inject drugs
- Open Access
- 23 March 2026
- Published by Elsevier in The Lancet Digital Health
- Vol. 8 (3) , 100992
Interpreting the GRACE 3.0 ITE model: from predictive performance to clinical decision utility
- 23 March 2026
- Published by Elsevier in The Lancet Digital Health
- Vol. 8 (3) , 100992
Open AccessInterpreting the GRACE 3.0 ITE model: from predictive performance to clinical decision utility
Clarifying the decision rules and implementation boundaries for risk-based HCC surveillance in MASLD
- 20 January 2026
- Published by Elsevier in Clinica Chimica Acta
- Vol. 584, 120848
ALT-triggered reflex AST testing in health check-ups: A decision curve analysis
- 20 January 2026
- Published by Elsevier in Clinica Chimica Acta
- Vol. 584, 120848
ALT-triggered reflex AST testing in health check-ups: A decision curve analysis
- 6 January 2026
- Published by Wolters Kluwer Health in Hepatology
- Vol. 84 (1) , E24-E25
Letter to the Editor: Interpreting the clinical decision value of glycomic-based models for early HCC detection in CHB
- 6 January 2026
- Published by Wolters Kluwer Health in Hepatology
- Vol. 84 (1) , E24-E25
Letter to the Editor: Interpreting the clinical decision value of glycomic-based models for early HCC detection in CHB